BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Staehler MD, Kruse J, Haseke N, Stadler T, Roosen A, Karl A, Stief CG, Jauch KW, Bruns CJ. Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis. World J Urol. 2010;28:543-547. [PMID: 20440505 DOI: 10.1007/s00345-010-0560-4] [Cited by in Crossref: 92] [Cited by in F6Publishing: 71] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Schwarz C, Kaczirek K, Bodingbauer M. Liver resection for non-colorectal metastases. Eur Surg 2018;50:113-6. [PMID: 29875799 DOI: 10.1007/s10353-018-0528-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ljungberg B. The Role of Metastasectomy in Renal Cell Carcinoma in the Era of Targeted Therapy. Curr Urol Rep 2013;14:19-25. [DOI: 10.1007/s11934-012-0293-6] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 4.4] [Reference Citation Analysis]
3 De Raffele E, Mirarchi M, Casadei R, Ricci C, Brunocilla E, Minni F. Twenty-year survival after iterative surgery for metastatic renal cell carcinoma: A case report and review of literature. World J Clin Cases 2020; 8(19): 4450-4465 [PMID: 33083404 DOI: 10.12998/wjcc.v8.i19.4450] [Cited by in CrossRef: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Shinohara N, Abe T. Prognostic factors and risk classifications for patients with metastatic renal cell carcinoma. Int J Urol 2015;22:888-97. [DOI: 10.1111/iju.12858] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
5 Staehler M. The role of metastasectomy in metastatic renal cell carcinoma. Nat Rev Urol 2011;8:180-1. [DOI: 10.1038/nrurol.2011.30] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
6 Fleckenstein FN, Schernthaner RE, Duran R, Sohn JH, Sahu S, Marshall K, Lin M, Gebauer B, Chapiro J, Salem R, Geschwind JF. Renal Cell Carcinoma Metastatic to the Liver: Early Response Assessment after Intraarterial Therapy Using 3D Quantitative Tumor Enhancement Analysis. Transl Oncol 2016;9:377-83. [PMID: 27641641 DOI: 10.1016/j.tranon.2016.07.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
7 Abdelmaksoud MH, Louie JD, Hwang GL, Kothary N, Minor DR, Sze DY. Yttrium-90 radioembolization of renal cell carcinoma metastatic to the liver. J Vasc Interv Radiol. 2012;23:323-330.e1. [PMID: 22277275 DOI: 10.1016/j.jvir.2011.11.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
8 Roos FC, Thüroff JW. [Resecting hematogenous metastases: reasons against]. Urologe A 2014;53:817-22. [PMID: 24824465 DOI: 10.1007/s00120-014-3467-7] [Reference Citation Analysis]
9 Hamada S, Ito K, Kuroda K, Sato A, Asakuma J, Horiguchi A, Seguchi K, Asano T. Clinical characteristics and prognosis of patients with renal cell carcinoma and liver metastasis. Mol Clin Oncol 2015;3:63-8. [PMID: 25469271 DOI: 10.3892/mco.2014.432] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
10 Mennitto A, Verzoni E, Calareso G, Spreafico C, Procopio G. Treatment of Advanced Renal Cell Carcinoma: Recent Advances and Current Role of Immunotherapy, Surgery, and Cryotherapy. Tumori 2017;103:15-21. [DOI: 10.5301/tj.5000581] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
11 Ran B, Cheng L, Kang L, Aji T, Jiang T, Zhang R, Guo Q, Wen H, Shao Y, Xiao H. Treatment of Hepatic Cystic Echinococcosis Patients with Clear Cell Renal Carcinoma: A Case Report. Open Life Sci 2019;14:647-50. [PMID: 33817203 DOI: 10.1515/biol-2019-0073] [Reference Citation Analysis]
12 Mennitto A, Verzoni E, Grassi P, Ratta R, Fucà G, Procopio G. Multimodal treatment of advanced renal cancer in 2017. Expert Review of Clinical Pharmacology 2017;10:1395-402. [DOI: 10.1080/17512433.2017.1386552] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
13 Brehmer B, Piper C, Pfister D, Porres D, Heidenreich A. [Metastasectomy for renal cell cancer]. Urologe A 2012;51:1202-8. [PMID: 22733397 DOI: 10.1007/s00120-012-2872-z] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
14 Vuyyala S, Gandhi S, Kuechle JB, George S. Complete Remission of Bone Metastases in Renal Cell Carcinoma with Nivolumab. Cureus 2019;11:e5531. [PMID: 31687305 DOI: 10.7759/cureus.5531] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Josephides E, Rodriguez-Vida A, Galazi M, Chowdhury S, Suder A. The role of metastasectomy in renal cell carcinoma. Expert Rev Anticancer Ther 2013;13:1363-71. [PMID: 24236818 DOI: 10.1586/14737140.2013.856762] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
16 Takemura N, Saiura A. Role of surgical resection for non-colorectal non-neuroendocrine liver metastases. World J Hepatol 2017; 9(5): 242-251 [PMID: 28261381 DOI: 10.4254/wjh.v9.i5.242] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
17 Soares A, Monteiro FSM, Maluf FC, Bastos DA, Jardim DL, Sasse AD, Gonçalves E Silva A, Fay AP, da Rosa DAR, Wierman E, Kater F, Schutz FA, de Oliveira FNG, Morbeck IAP, Rinck JA Jr, da Trindade KM, Maia MC, Souza VC, da Silva Neto DCV, de Almeida E Paula F, Korkes F, Carvalhal GF, Nogueira L, de Carvalho Fernandes R, Dos Reis RB, Matheus WE, Busato WFS Jr, da Costa WH, de Cássio Zequi S. Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG). J Cancer Res Clin Oncol 2020;146:1829-45. [PMID: 32410064 DOI: 10.1007/s00432-020-03236-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Lang EK, Hanano A, Nguyen Q. Inferior vena cava tumor thrombus (renal cell carcinoma) extending into hepatic veins. J Urol 2011;185:1475. [PMID: 21334673 DOI: 10.1016/j.juro.2011.01.009] [Reference Citation Analysis]
19 Hau HM, Thalmann F, Lübbert C, Morgul MH, Schmelzle M, Atanasov G, Benzing C, Lange U, Ascherl R, Ganzer R, Uhlmann D, Tautenhahn HM, Wiltberger G, Bartels M. The value of hepatic resection in metastasic renal cancer in the Era of Tyrosinkinase Inhibitor Therapy. BMC Surg 2016;16:49. [PMID: 27444582 DOI: 10.1186/s12893-016-0163-0] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
20 Burger M. [Is surgical treatment ever indicated in metastatic renal cell carcinoma and if so, based on which scientific rationale?]. Urologe A 2017;56:617-23. [PMID: 28314970 DOI: 10.1007/s00120-017-0357-9] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
21 Dr Hall B, Abel EJ. The Evolving Role of Metastasectomy for Patients with Metastatic Renal Cell Carcinoma. Urol Clin North Am 2020;47:379-88. [PMID: 32600539 DOI: 10.1016/j.ucl.2020.04.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Mitomo S, Takahara T, Nitta H, Fujita T, Ito N, Uesugi N, Sugai T, Wakabayashi G. Sunitinib treatment enabling resection of massive liver metastasis: a case report. J Med Case Rep 2013;7:234. [PMID: 24090151 DOI: 10.1186/1752-1947-7-234] [Reference Citation Analysis]
23 Lin H, Zhang H, Cheng Y, Zhang C. Solitary Metastasis in the Mediastinal Lymph Node After Radical Nephrectomy for Clear Cell Renal Cell Carcinoma: A Case Report and Literature Review. Front Oncol 2020;10:593142. [PMID: 33392088 DOI: 10.3389/fonc.2020.593142] [Reference Citation Analysis]
24 Kawashima A, Nakayama M, Oka D, Sato M, Hatano K, Mukai M, Nagahara A, Nakai Y, Takayama H, Inoue M, Shiono H, Nishimura K, Okumura M, Nonomura N. Pulmonary metastasectomy in patients with renal cell carcinoma: a single-institution experience. Int J Clin Oncol 2011;16:660-5. [DOI: 10.1007/s10147-011-0244-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
25 Langan RC, Ripley RT, Davis JL, Prieto PA, Datrice N, Steinberg SM, Bratslavsky G, Rudloff U, Kammula US, Stojadinovic A. Liver directed therapy for renal cell carcinoma. J Cancer. 2012;3:184-190. [PMID: 22558019 DOI: 10.7150/jca.4456] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
26 Joyce DD, Psutka SP, Groeschl RT, Thompson RH, Boorjian SA, Cheville JC, Stewart-merrill SB, Lohse CM, Costello BA, Que FG, Leibovich BC. Complications and Outcomes Associated With Surgical Management of Renal Cell Carcinoma Involving the Liver: A Matched Cohort Study. Urology 2017;99:155-61. [DOI: 10.1016/j.urology.2016.08.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
27 Bex A, Larkin J, Voss M. Challenging the treatment paradigm for advanced renal cell carcinoma: a review of systemic and localized therapies. Am Soc Clin Oncol Educ Book 2015;:e239-47. [PMID: 25993179 DOI: 10.14694/EdBook_AM.2015.35.e239] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
28 Wahba R, Stippel D, Bruns C. Die Rolle der Viszeralchirurgie bei Oligometastasierung nichtgastrointestinaler Tumoren. Chirurg 2018;89:523-8. [DOI: 10.1007/s00104-018-0647-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Nguyen DH, Truong PT, Walter CV, Hayashi E, Christie JL, Alexander C. Limited M1 disease: a significant prognostic factor for stage IV breast cancer. Ann Surg Oncol 2012;19:3028-34. [PMID: 22476751 DOI: 10.1245/s10434-012-2333-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
30 Pierro M, Raychaudhuri R, Lea WB, Rilling W, Davis N, Bylow K, Kilari D. Outcomes With Liver-Directed Therapy for Genitourinary Malignancies: Single-Institution Experience. Clin Genitourin Cancer 2021;19:87-91. [PMID: 32778506 DOI: 10.1016/j.clgc.2020.07.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Tonyali S, Yazici S. Does solitary- and organ-confined metastasectomy really improve survival in advanced urologic malignancies? Int Urol Nephrol 2016;48:671-80. [DOI: 10.1007/s11255-016-1226-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
32 Schneider G, Probst T, Kirchin MA, Stroeder J, Fries P, Buecker A. Low-dose gadobenate dimeglumine-enhanced MRI of the kidney for the differential diagnosis of localized renal lesions. Radiol Med 2015;120:1100-11. [PMID: 26088468 DOI: 10.1007/s11547-015-0548-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
33 Tosco L, Van Poppel H, Frea B, Gregoraci G, Joniau S. Survival and impact of clinical prognostic factors in surgically treated metastatic renal cell carcinoma. Eur Urol. 2013;63:646-652. [PMID: 23041360 DOI: 10.1016/j.eururo.2012.09.037] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 6.5] [Reference Citation Analysis]
34 Pikoulis E, Margonis GA, Antoniou E. Surgical Management of Renal Cell Cancer Liver Metastases. Scand J Surg 2016;105:263-8. [PMID: 26929295 DOI: 10.1177/1457496916630644] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
35 Kim SH, Park WS, Park B, Pak S, Chung J. A Retrospective Analysis of the Impact of Metastasectomy on Prognostic Survival According to Metastatic Organs in Patients With Metastatic Renal Cell Carcinoma. Front Oncol. 2019;9:413. [PMID: 31179242 DOI: 10.3389/fonc.2019.00413] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
36 Dabestani S, Marconi L, Hofmann F, Stewart F, Lam TB, Canfield SE, Staehler M, Powles T, Ljungberg B, Bex A. Local treatments for metastases of renal cell carcinoma: a systematic review. Lancet Oncol. 2014;15:e549-e561. [PMID: 25439697 DOI: 10.1016/s1470-2045(14)70235-9] [Cited by in Crossref: 165] [Cited by in F6Publishing: 73] [Article Influence: 20.6] [Reference Citation Analysis]
37 Kim C, Hoang CD, Kesarwala AH, Schrump DS, Guha U, Rajan A. Role of Local Ablative Therapy in Patients with Oligometastatic and Oligoprogressive Non-Small Cell Lung Cancer. J Thorac Oncol 2017;12:179-93. [PMID: 27780780 DOI: 10.1016/j.jtho.2016.10.012] [Cited by in Crossref: 39] [Cited by in F6Publishing: 45] [Article Influence: 6.5] [Reference Citation Analysis]
38 Schiergens TS, Lüning J, Renz BW, Thomas M, Pratschke S, Feng H, Lee SM, Engel J, Rentsch M, Guba M. Liver Resection for Non-colorectal Non-neuroendocrine Metastases: Where Do We Stand Today Compared to Colorectal Cancer? J Gastrointest Surg. 2016;20:1163-1172. [PMID: 26921025 DOI: 10.1007/s11605-016-3115-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
39 Omid S, Abufaraj M, Remzi M. Metastasectomy in patients with renal cell carcinoma: when and how? Curr Opin Urol 2020;30:602-9. [PMID: 32464043 DOI: 10.1097/MOU.0000000000000768] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Desai K, Brown L, Wei W, Tucker M, Kao C, Kinsey E, Rini B, Beckermann K, Zhang T, Ornstein MC. A Multi-institutional, Retrospective Analysis of Patients with Metastatic Renal Cell Carcinoma to Bone Treated with Combination Ipilimumab and Nivolumab. Target Oncol 2021. [PMID: 34379283 DOI: 10.1007/s11523-021-00832-3] [Reference Citation Analysis]
41 Kis B, Shah J, Choi J, El-Haddad G, Sweeney J, Biebel B, Mellon E, Frakes JM, Hoffe SE, Fishman MN, Shridhar R. Transarterial Yttrium-90 Radioembolization Treatment of Patients with Liver-Dominant Metastatic Renal Cell Carcinoma. J Vasc Interv Radiol 2017;28:254-9. [PMID: 27955832 DOI: 10.1016/j.jvir.2016.09.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
42 Sun M, Meyer CP, Karam JA, de Velasco G, Chang SL, Pal SK, Trinh QD, Choueiri TK. Predictors, utilization patterns, and overall survival of patients undergoing metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy. Eur J Surg Oncol. 2018;44:1439-1445. [PMID: 29935840 DOI: 10.1016/j.ejso.2018.05.026] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
43 Cho Y, Chang JS, Rha KH, Hong SJ, Choi YD, Ham WS, Kim JW, Cho J. Does Radiotherapy for the Primary Tumor Benefit Prostate Cancer Patients with Distant Metastasis at Initial Diagnosis? PLoS One 2016;11:e0147191. [PMID: 26807740 DOI: 10.1371/journal.pone.0147191] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
44 Chatzizacharias NA, Rosich-Medina A, Dajani K, Harper S, Huguet E, Liau SS, Praseedom RK, Jah A. Surgical management of hepato-pancreatic metastasis from renal cell carcinoma. World J Gastrointest Oncol 2017; 9(2): 70-77 [PMID: 28255428 DOI: 10.4251/wjgo.v9.i2.70] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
45 Martel G, Bertens KA, Canil C. Surgical Management of Genitourinary Cancer Liver Metastases. Surg Oncol Clin N Am 2021;30:89-102. [PMID: 33220811 DOI: 10.1016/j.soc.2020.08.003] [Reference Citation Analysis]
46 Bex A. Integrating metastasectomy and stereotaxic radiosurgery in the treatment of metastatic renal cell carcinoma. EJC Supplements. 2013;2:192-203. [PMID: 26217128 DOI: 10.1016/j.ejcsup.2013.07.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
47 Hsieh PY, Hung SC, Li JR, Wang SS, Yang CK, Chen CS, Lu K, Cheng CL, Chiu KY. The effect of metastasectomy on overall survival in metastatic renal cell carcinoma: A systematic review and meta-analysis. Urol Oncol 2021;39:422-30. [PMID: 33934963 DOI: 10.1016/j.urolonc.2021.02.026] [Reference Citation Analysis]
48 Maciolek KA, Abel EJ, Best SL, Emamekhoo H, Averill SL, Ziemlewicz TJ, Lubner MG, Hinshaw JL, Lee FT, Wells SA. Percutaneous microwave ablation for local control of metastatic renal cell carcinoma. Abdom Radiol 2018;43:2446-54. [DOI: 10.1007/s00261-018-1498-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
49 Loh J, Davis ID, Martin JM, Siva S. Extracranial oligometastatic renal cell carcinoma: current management and future directions. Future Oncol 2014;10:761-74. [PMID: 24799057 DOI: 10.2217/fon.14.40] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
50 Liu Y, Long W, Zhang Z, Zhang Z, Mai L, Huang S, Han H, Zhou F, Dong P, He L. Metastasis-directed stereotactic body radiotherapy for oligometastatic renal cell carcinoma: extent of tumor burden eradicated by radiotherapy. World J Urol 2021. [PMID: 34043023 DOI: 10.1007/s00345-021-03742-1] [Reference Citation Analysis]
51 van Oostenbrugge TJ, Kroeze SGC, Bosch JLHR, van Melick HHE. The blind spots in follow-up after nephrectomy or nephron-sparing surgery for localized renal cell carcinoma. World J Urol 2015;33:881-7. [DOI: 10.1007/s00345-014-1390-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
52 González J, Gaynor JJ, Alameddine M, Esteban M, Ciancio G. Indications, complications, and outcomes following surgical management of locally advanced and metastatic renal cell carcinoma. Expert Rev Anticancer Ther 2018;18:237-50. [PMID: 29353520 DOI: 10.1080/14737140.2018.1431530] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
53 Husillos Alonso A, Carbonero García M, González Enguita C. Is there a role for systemic targeted therapy after surgical treatment for metastases of renal cell carcinoma? World J Nephrol 2015; 4(2): 254-262 [PMID: 25949939 DOI: 10.5527/wjn.v4.i2.254] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
54 Ingrosso G, Becherini C, Francolini G, Lancia A, Alì E, Caini S, Teriaca MA, Marchionni A, Filippi AR, Livi L, Sanguineti G, Aristei C, Detti B. Stereotactic body radiotherapy (SBRT) in combination with drugs in metastatic kidney cancer: A systematic review. Crit Rev Oncol Hematol 2021;159:103242. [PMID: 33545356 DOI: 10.1016/j.critrevonc.2021.103242] [Reference Citation Analysis]
55 Lieder A, Guenzel T, Lebentrau S, Schneider C, Franzen A. Diagnostic relevance of metastatic renal cell carcinoma in the head and neck: An evaluation of 22 cases in 671 patients. Int Braz J Urol 2017;43:202-8. [PMID: 27649110 DOI: 10.1590/S1677-5538.IBJU.2015.0665] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
56 Dabestani S, Marconi L, Bex A. Metastasis therapies for renal cancer. Curr Opin Urol. 2016;26:566-572. [PMID: 27471993 DOI: 10.1097/mou.0000000000000330] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 5.8] [Reference Citation Analysis]
57 Staehler M, Tüllmann C, Nuhn P, Haseke N, Stief CG. [Systemic therapy of renal cell carcinoma]. Urologe A 2010;49:1543-50; quiz 1551. [PMID: 21113574 DOI: 10.1007/s00120-010-2446-x] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
58 Beetz O, Söffker R, Cammann S, Oldhafer F, Vondran FWR, Imkamp F, Klempnauer J, Kleine M. Extended hepatic metastasectomy for renal cell carcinoma-new aspects in times of targeted therapy: a single-center experience over three decades. Langenbecks Arch Surg 2020;405:97-106. [PMID: 31938833 DOI: 10.1007/s00423-019-01852-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
59 Heidenreich A, Wilop S, Pinkawa M, Porres D, Pfister D. Surgical resection of urological tumor metastases following medical treatment. Dtsch Arztebl Int 2012;109:631-7. [PMID: 23093995 DOI: 10.3238/arztebl.2012.0631] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
60 Fitzgerald TL, Brinkley J, Banks S, Vohra N, Englert ZP, Zervos EE. The benefits of liver resection for non-colorectal, non-neuroendocrine liver metastases: a systematic review. Langenbecks Arch Surg. 2014;399:989-1000. [PMID: 25148767 DOI: 10.1007/s00423-014-1241-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
61 Apollonio G, Raimondi A, Verzoni E, Claps M, Sepe P, Pagani F, Ratta R, Montorsi F, De Braud FGM, Procopio G. The role of metastasectomy in advanced renal cell carcinoma. Expert Review of Anticancer Therapy 2019;19:603-11. [DOI: 10.1080/14737140.2019.1625772] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
62 Zaid HB, Parker WP, Safdar NS, Gershman B, Erwin PJ, Murad MH, Boorjian SA, Costello BA, Thompson RH, Leibovich BC. Outcomes Following Complete Surgical Metastasectomy for Patients with Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. J Urol. 2017;197:44-49. [PMID: 27473875 DOI: 10.1016/j.juro.2016.07.079] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 9.5] [Reference Citation Analysis]
63 Tricard T, Tsoumakidou G, Lindner V, Garnon J, Albrand G, Cathelineau X, Gangi A, Lang H. Thérapies ablatives dans le cancer du rein : indications. Progrès en Urologie 2017;27:926-51. [DOI: 10.1016/j.purol.2017.07.245] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
64 Ouzaid I, Capitanio U, Staehler M, Wood CG, Leibovich BC, Ljungberg B, Van Poppel H, Bensalah K; Young Academic Urologists Kidney Cancer Working Group of the European Association of Urology. Surgical Metastasectomy in Renal Cell Carcinoma: A Systematic Review. Eur Urol Oncol. 2019;2:141-149. [PMID: 31017089 DOI: 10.1016/j.euo.2018.08.028] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]
65 Buchner A, Kendlbacher M, Nuhn P, Tüllmann C, Haseke N, Stief CG, Staehler M. Outcome assessment of patients with metastatic renal cell carcinoma under systemic therapy using artificial neural networks. Clin Genitourin Cancer 2012;10:37-42. [PMID: 22056212 DOI: 10.1016/j.clgc.2011.10.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
66 Pinotti E, Montuori M, Giani A, Uggeri F, Garancini M, Gianotti L, Romano F. Surgical treatment of liver metastases from kidney cancer: a systematic review. ANZ J Surg. 2019;89:32-37. [PMID: 30685878 DOI: 10.1111/ans.15000] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
67 Rodler S, Schott M, Tamalunas A, Marcon J, Graser A, Mumm JN, Casuscelli J, Stief CG, Fürweger C, Muacevic A, Staehler M. Safety and Efficacy of Robotic Radiosurgery for Visceral and Lymph Node Metastases of Renal Cell Carcinoma: A Retrospective, Single Center Analysis. Cancers (Basel) 2021;13:680. [PMID: 33567564 DOI: 10.3390/cancers13040680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Kramer MW, Merseburger AS, Peters I, Waalkes S, Kuczyk MA. [Systemic and surgical management of metastatic renal cell carcinoma]. Urologe A 2012;51:217-25. [PMID: 22009257 DOI: 10.1007/s00120-011-2713-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
69 Matsuda H, Tamada S, Kato M, Yamamoto A, Iguchi T, Nakatani T. Transarterial chemoembolization of liver metastasis from renal cell carcinoma. Urol Case Rep 2018;17:79-81. [PMID: 29541587 DOI: 10.1016/j.eucr.2018.01.015] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
70 Yücel ÖB, Tunç HM, Başaran M, Aras N. 22-year survival following radical nephrectomy and several metastasectomies in a case of renal cell carcinoma. Turk J Urol 2017;43:216-9. [PMID: 28717549 DOI: 10.5152/tud.2017.04372] [Reference Citation Analysis]
71 Jakubowski CD, Vertosick EA, Untch BR, Sjoberg D, Wei E, Palmer FL, Patel SG, Downey RJ, Strong VE, Russo P. Complete metastasectomy for renal cell carcinoma: Comparison of five solid organ sites. J Surg Oncol 2016;114:375-9. [PMID: 27338155 DOI: 10.1002/jso.24327] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
72 Slotta JE, Schuld J, Distler S, Richter S, Schilling MK, Kollmar O. Hepatic resection of non-colorectal and non-neuroendocrine liver metastases - survival benefit for patients with non-gastrointestinal primary cancers - a case-controlled study. Int J Surg 2014;12:163-8. [PMID: 24342081 DOI: 10.1016/j.ijsu.2013.12.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
73 Neri F, Ercolani G, Di Gioia P, Del Gaudio M, Pinna AD. Liver metastases from non-gastrointestinal non-neuroendocrine tumours: review of the literature. Updates Surg 2015;67:223-33. [PMID: 26341625 DOI: 10.1007/s13304-015-0315-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
74 Thomas AZ, Adibi M, Borregales LD, Wood CG, Karam JA. Role of metastasectomy in metastatic renal cell carcinoma. Current Opinion in Urology 2015;25:381-9. [DOI: 10.1097/mou.0000000000000196] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
75 Achkar T, Maranchie JK, Appleman LJ. Metastasectomy in Advanced Renal Cell Carcinoma: A Systematic Review. KCA 2019;3:31-40. [DOI: 10.3233/kca-180042] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
76 Hatzaras I, Gleisner AL, Pulitano C, Sandroussi C, Hirose K, Hyder O, Wolfgang CL, Aldrighetti L, Crawford M, Choti MA, Pawlik TM. A multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell cancer. HPB (Oxford). 2012;14:532-538. [PMID: 22762401 DOI: 10.1111/j.1477-2574.2012.00495.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]